Corporate Finance
140 Corporate Finance Refer to the following data: Balance sheet 1994 1995 Assets Net fixed assets 14,000 14,800 Current ass ...
Financial Statements and Firm Value 141 1982 1983 1984 Others 736 1,571 2,066 Current assets – – – Total 63,746 56,880 67,092 ...
142 Corporate Finance Chapter 6 23. A Case Study: Bermuda Airways and Industry Structure OBJECTIVES Introduce students to th ...
Financial Statements and Industry Structure 143 Exhibit 6.1 Balance sheet (in percent) and financial data ABCDEF Structure of ...
144 Corporate Finance The Solution A good way to segregate companies is to classify them as service and manufacturing companie ...
Financial Performance of Pharmaceutical Companies 145 Chapter 7 26. A Case Study: Financing NTPC Financial Performance of Phar ...
146 Corporate Finance The Indian pharmaceutical market was estimated at $3 billion in 1997 in terms of volume consumed. From t ...
Financial Performance of Pharmaceutical Companies 147 Central and decided to put up a first class modern pharmaceutical works ...
148 Corporate Finance Dr Reddy’s Laboratories (DRL) was incorporated in February 1984, by promoters Dr Anji Reddy and Mr M.P. ...
Financial Performance of Pharmaceutical Companies 149 Exhibit 7.4 Pharmaceutical firms—income statement (Rs crore) Glaxo Ranba ...
Exhibit 7.5(a) Pharmaceutical firms—common size balance sheet (Percentage of total assets) Glaxo Ranbaxy Cipla Sun DRL 2001 2000 ...
Exhibit 7.5(b) Pharmaceutical firms—common size income statement (Percentage of sales) Glaxo Ranbaxy Cipla Sun DRL 2001 2000 200 ...
Exhibit 7.6 Pharmaceutical firms—statement of cash flows Cash flow statement Glaxo Ranbaxy Cipla Sun DRL (Rs crore) Dec-00 Dec-0 ...
Exhibit 7.7 Select financial ratios and data Glaxo Ranbaxy Cipla Sun DRL 2001 2000 2001 2000 2001 2000 2001 2000 2001 2000 Inven ...
154 Corporate Finance Glaxo Ranbaxy Cipla Sun DRL 2001 2000 2001 2000 2001 2000 2001 2000 2001 2000 ProfitabilityEBDIT/total a ...
Financial Performance of Pharmaceutical Companies 155 Return on assets = EBIT/Assets Return on equity = Net income/Equity Stoc ...
156 Corporate Finance The data indicates that in terms of total assets the fastest (slowest) growth was reported by DRL (Ranba ...
Financial Performance of Pharmaceutical Companies 157 All firms decreased their debt levels except for DRL. Glaxo, for example ...
158 Corporate Finance Exhibit 7.8 Stock price histories of pharmaceutical companies Glaxo SmithKline Ranbaxy Laboratories 303. ...
Financial Performance of Pharmaceutical Companies 159 Exhibit 7.9 EBITDA margins (in percent) 1997 1998 Cipla 22.6 24.2 DRL 20 ...
«
3
4
5
6
7
8
9
10
11
12
»
Free download pdf